SCHEMBL30020899

SCHEMBL30020899

CCCCCCCCCCCC(=O)NCCCCCCNC(=O)C(CCCCNC(=O)OCC1c2ccccc2-c2ccccc21)NC(=O)OC(C)(C)C

nearest known ligand 0.68

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.53
▸ SIRT2 Q8IXJ6 4/20 0.53
▸ TLR2 O60603 7/20 0.52
▸ TLR1 Q15399 1/20 0.50
▸ SIRT1 Q96EB6 2/20 0.46
▸ SIRT3 Q9NTG7 2/20 0.46
▸ KLK7 P49862 1/20 0.44
▸ KLK5 Q9Y337 1/20 0.44
▸ BCHE P06276 1/20 0.44
▸ ACHE P22303 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14086301 0.94 KMT2A (0.53) KMT2ASIRT2TLR2TLR1KLK7
SCHEMBL14073719 0.94 KMT2A (0.53) KMT2ASIRT2TLR2TLR1KLK7
SCHEMBL14073721 0.92 KMT2A (0.54) KMT2ASIRT2TLR2TLR1KLK7
SCHEMBL14086305 0.92 KMT2A (0.54) KMT2ASIRT2TLR2TLR1KLK7
SCHEMBL30019865 0.92 TLR2 (0.50) KMT2ASIRT2TLR2TLR1SIRT1
SCHEMBL30020706 0.92 TLR2 (0.50) KMT2ASIRT2TLR2TLR1SIRT1
SCHEMBL16328803 0.92 TLR2 (0.59) KMT2ASIRT2TLR2TLR1SIRT1
SCHEMBL30020633 0.90 TLR2 (0.53) KMT2ASIRT2TLR2SIRT1SIRT3
SCHEMBL30020181 0.90 TLR2 (0.50) KMT2ASIRT2TLR2TLR1SIRT1
SCHEMBL16185928 0.89 TLR2 (0.53) KMT2ATLR2TLR1KLK7KLK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4326741-A1 CYCLOPOLYPHOSPHAZENES, RELATED METHODS OF PREPARATION AND METHODS OF USE University of Saskatchewan (CA) 2024-02-28 — — EP disclosed
WO-2022221959-A1 CYCLOPOLYPHOSPHAZENES, RELATED METHODS OF PREPARATION AND METHODS OF USE UNIVERSITY OF SASKATCHEWAN (CA) 2022-10-27 — — WO disclosed
Send feedback